Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sajitha Sachchithanantham

Showing results (11-20 of 58) with videos related to

Pageof 6
Sort By:
Haematologica|August 22, 2015
Clinical profile and treatment outcome of older (>75 years) patients with systemic AL amyloidosisSajitha Sachchithanantham, Mark Offer, Christopher Venner, et al.
Blood Cancer Journal|November 7, 2018
Deferred autologous stem cell transplantation in systemic AL amyloidosisRicha Manwani, Ute Hegenbart, Shameem Mahmood, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 27, 2026
Progressive Multifocal Leukoencephalopathy (PML) in 2 Patients Treated With ElranatamabOliver Tomkins, Rea Grace Maamari, Sam Douthwaite, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2016
European Collaborative Study Defining Clinical Profile Outcomes and Novel Prognostic Criteria in Monoclonal Immunoglobulin M-Related Light Chain AmyloidosisSajitha Sachchithanantham, Murielle Roussel, Giovanni Palladini, et al.
American Journal of Clinical Pathology|June 30, 2016
Comparison of Free Light Chain Assays:  Freelite and N Latex in Diagnosis, Monitoring, and Predicting Survival in Light Chain AmyloidosisShameem Mahmood, Nancy L Wassef, Simon J Salter, et al.
European Journal of Haematology|December 10, 2019
Cytomegalovirus reactivation after bortezomib treatment for multiple myeloma and light chain amyloidosisFaye A Sharpley, Dunnya De-Silva, Shameem Mahmood, et al.
Haematologica|August 11, 2019
Cardiac biomarkers are prognostic in systemic light chain amyloidosis with no cardiac involvement by standard criteriaFaye A Sharpley, Marianna Fontana, Ana Martinez-Naharro, et al.
Blood|October 4, 2019
A prospective observational study of 915 patients with systemic AL amyloidosis treated with upfront bortezomibRicha Manwani, Oliver Cohen, Faye Sharpley, et al.
European Heart Journal|January 1, 2015
A study of implanted cardiac rhythm recorders in advanced cardiac AL amyloidosisRabya H Sayed, Dominic Rogers, Fakhar Khan, et al.
Sleep Medicine|April 4, 2017
High prevalence of recurrent nocturnal desaturations in systemic AL amyloidosis: a cross-sectional pilot studyShameem Mahmood, Milind Sovani, Peter Smith, et al.
Pageof 6

Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
Haematologica|August 22, 2015
Clinical profile and treatment outcome of older (>75 years) patients with systemic AL amyloidosisSajitha Sachchithanantham, Mark Offer, Christopher Venner, et al.
Blood Cancer Journal|November 7, 2018
Deferred autologous stem cell transplantation in systemic AL amyloidosisRicha Manwani, Ute Hegenbart, Shameem Mahmood, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 27, 2026
Progressive Multifocal Leukoencephalopathy (PML) in 2 Patients Treated With ElranatamabOliver Tomkins, Rea Grace Maamari, Sam Douthwaite, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2016
European Collaborative Study Defining Clinical Profile Outcomes and Novel Prognostic Criteria in Monoclonal Immunoglobulin M-Related Light Chain AmyloidosisSajitha Sachchithanantham, Murielle Roussel, Giovanni Palladini, et al.
American Journal of Clinical Pathology|June 30, 2016
Comparison of Free Light Chain Assays:  Freelite and N Latex in Diagnosis, Monitoring, and Predicting Survival in Light Chain AmyloidosisShameem Mahmood, Nancy L Wassef, Simon J Salter, et al.
European Journal of Haematology|December 10, 2019
Cytomegalovirus reactivation after bortezomib treatment for multiple myeloma and light chain amyloidosisFaye A Sharpley, Dunnya De-Silva, Shameem Mahmood, et al.
Haematologica|August 11, 2019
Cardiac biomarkers are prognostic in systemic light chain amyloidosis with no cardiac involvement by standard criteriaFaye A Sharpley, Marianna Fontana, Ana Martinez-Naharro, et al.
Blood|October 4, 2019
A prospective observational study of 915 patients with systemic AL amyloidosis treated with upfront bortezomibRicha Manwani, Oliver Cohen, Faye Sharpley, et al.
European Heart Journal|January 1, 2015
A study of implanted cardiac rhythm recorders in advanced cardiac AL amyloidosisRabya H Sayed, Dominic Rogers, Fakhar Khan, et al.
Sleep Medicine|April 4, 2017
High prevalence of recurrent nocturnal desaturations in systemic AL amyloidosis: a cross-sectional pilot studyShameem Mahmood, Milind Sovani, Peter Smith, et al.
Pageof 6